Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Q&A: Amar Urhekar

Q&A: Amar Urhekar We worked together at McCann in Japan. Just before his 30th birthday, he was diagnosed with ALS.

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC

BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC As part of that agreement, Novartis gained development and commercialisation rights to tislelizumab in the US, Canada, Mexico, the EU, UK, Norway, Switzerland, Iceland, Liechtenstein, Russia and Japan for an upfront

A new era for UK-Japanese scientific research relations

A new era for UK-Japanese scientific research relations Japan’s healthcare needs. Japan’s healthcare economy has evolved immensely since WWII. ... Historically, Japan has struggled to recruit patients and conduct trials within its domestic population.

Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition

Amgen adds to oncology pipeline with $1.9bn Five Prime Therapeutics acquisition The company said its would leverage its presence in Japan and other Asia-Pacific markets to maximise the potential of bemarituzumab in the gastric cancer market.

Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds

Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds Using this approach, the analysis found that five countries – Australia, Canada, Japan, the UK and the US – plus the European Union, that is made up of 27 member states, could share

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....